An editorial notes this trial had several limitations, such as lack of blinding, that introduces opportunities for bias. Furthermore, the study was not powered to fully characterise either class-specific risks for postpolypectomy bleeding in patients using warfarin versus those receiving direct oral anticoagulants or the rate of residual adenoma (incomplete polyp resection), which are important considerations in clinical practice. It also did not compare outcomes of continuous administration of anticoagulants with either cold or hot snare polypectomy with those of simply holding anticoagulation without heparin bridging, a strategy commonly used for persons perceived to have a low thromboembolic risk. It concludes that this study adds to emerging evidence that small colorectal polyps may be resected safely with cold snare polypectomy while oral anticoagulation continues and provides the first comparative evidence that this strategy may be safer than heparin bridging plus hot snare polypectomy. The results warrant confirmatory studies.